ArticleScientific reports2021

Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients.

Hasinika K A H Gamage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.